We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Confidential Treatment Requested under 17 C.F.R. Sections 200.80(b)(4) and 230.406 andAssignment and Exclusive Licence • May 1st, 2015 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledMay 1st, 2015 Company Industry Jurisdiction
Confidential Treatment Requested under 17 C.F.R. Sections 200.80(b)(4) and 230.406 andAssignment and Exclusive Licence • April 27th, 2015 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledApril 27th, 2015 Company Industry Jurisdiction